Pemazyre Interactions
There are 294 drugs known to interact with Pemazyre (pemigatinib), along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 78 are major, 214 are moderate, and 2 are minor.
- View all 294 medications that may interact with Pemazyre
- View Pemazyre alcohol/food interactions (1)
- View Pemazyre disease interactions (1)
Most frequently checked interactions
View interaction reports for Pemazyre (pemigatinib) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- alpha-lipoic acid
- alprazolam
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- amitriptyline
- Amondys 45 (casimersen)
- ampicillin
- Amvuttra (vutrisiran)
- apremilast
- Aspercreme Maximum Strength Lidocaine Patch (lidocaine topical)
- Aspirin Low Strength (aspirin)
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Avodart (dutasteride)
- B-12 Dots (cyanocobalamin)
- clonazepam
- Cymbalta (duloxetine)
- melatonin
- metformin
- nitroglycerin
- Ozempic (semaglutide)
- pantoprazole
- Vitamin D3 (cholecalciferol)
Pemazyre alcohol/food interactions
There is 1 alcohol/food interaction with Pemazyre (pemigatinib).
Pemazyre disease interactions
There is 1 disease interaction with Pemazyre (pemigatinib) which include:
Report options
More about Pemazyre (pemigatinib)
- Pemazyre consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Lytgobi
Lytgobi (futibatinib) is used for the treatment of bile duct cancer (intrahepatic ...
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Alunbrig
Alunbrig (brigatinib) is used to treat anaplastic lymphoma kinase-positive (ALK+) metastatic ...
Augtyro
Augtyro (repotrectinib) is a next-generation TKI (Tyrosine Kinase Inhibitor) cancer medicine used ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
